HOME >> BIOLOGY >> NEWS
JCI table of contents July 1, 2005

EDITORS' PICK

Monkeying around to improve organ transplantation

Organ transplantation is accompanied by nonspecific immune suppression therapy to prevent T cell-mediated rejection. These immunosuppressants can cause infection, hypertension, cancer, and other undesirable side effects. Therefore, specific suppression of the T cells that attack the transplanted organ is needed.

It was known that anergic T cells (immune T cells that do not respond to antigen stimulation) generated in an artificial environment outside the living organism have immunosuppressive activity in vitro. Now in a study appearing online on June 9 in advance of the print publication of the July 1 print issue of the Journal of Clinical Investigation, Hisashi Bashuda and colleagues from Juntendo University investigate whether this approach can induce indefinite organ allograft survival in vivo, in six rhesus monkeys.

The authors stimulate recipient T cells from the monkeys with donor cells under conditions associated with the development of T cell anergy. Reinfusion of these cells into the recipient after kidney transplantation leads to very prolonged 880 days and perhaps even indefinite graft survival in three long-surviving animals without administration of additional immunosuppressive agents. This study shows for the first time that anergic T cells generated ex vivo suppress renal allograft rejection in non-human primates. This may be an approach that could be used in human transplant trials.

Title: Renal allograft rejection is prevented by adoptive transfer of anergic T cells in non-human primates

AUTHOR CONTACT:
Hisashi Bashuda
Juntendo University School of Medicine, Tokyo, Japan
Phone: 81-3-5802-1045; Fax: 81-3-3813-0421; E-mail: bashuda@med.juntendo.ac.jp

View the PDF of this article at: https://www.the-jci.
'"/>


Contact: Stacie Bloom
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
9-Jun-2005


Page: 1 2 3 4 5 6

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):
(Date:7/27/2017)... ... July 27, 2017 , ... ... businesses to participate in Lajollacooks4u’s popular corporate team building events this summer. ... in Lajollacooks4u’s signature olive oil competition to whet their palettes. Three teams ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... worldwide rights to SQuEEZ heart function analysis software, and an associated pending patent ... was filed April 10, 2014 and uses high resolution cardiac CT to analyze ...
(Date:7/26/2017)... Biosciences Inc., a world leading specialty CRO announced the publication ... early stage (latent) Mycobacterium tuberculosis (Mtb) infection using state-of-the-art ProteoCarta™, ... ... Caprion Biosciences Inc. (CNW Group/Caprion Biosciences) ... The new data, recently published in EbioMedicine ...
(Date:7/26/2017)... Ca (PRWEB) , ... July 25, 2017 , ... ... August 22, attendees will garner a better understanding of the considerations needed for ... CRISPR-Cas9 applications. , The use of CRISPR-Cas9 to create targeted double-strand breaks in ...
Breaking Biology Technology:
Cached News: